Matches in SemOpenAlex for { <https://semopenalex.org/work/W3117103641> ?p ?o ?g. }
- W3117103641 endingPage "e288" @default.
- W3117103641 startingPage "e267" @default.
- W3117103641 abstract "Background and Aims Hepatocellular carcinoma (HCC) is the fastest rising cause of cancer-related death in the United States; however, HCC incidence and mortality are not equally distributed among racial and ethnic groups. Our aim was to characterize the direction and magnitude of racial and ethnic disparities in overall survival and early tumor detection among patients with HCC. Methods We searched MEDLINE, EMBASE and Cochrane databases from inception through August 2020 for studies reporting HCC outcomes (early stage presentation and overall survival) by race and ethnicity. We calculated pooled hazard ratios (HRs) and odds ratios (ORs) for each racial and ethnic group (White, Black, Hispanic, Asian) using the DerSimonian and Laird method for a random-effects model. Results We identified 35 articles comprising 563,097 patients (53.0% White, 17.3% Black, 18.4% Hispanic, 5.0% Asian). Compared with White patients, Black patients had worse survival (pooled HR 1.08; 95% CI, 1.05 – 1.12), whereas Hispanic (pooled HR 0.92; 95% CI, 0.87 – 0.97) and Asian (pooled HR 0.81; 95% CI, 0.73 – 0.88) patients had better survival. Among articles reporting tumor stage (n = 20), Black patients had lower odds of early stage HCC compared with White patients (OR, 0.66; 95% CI, 0.54 – 0.78). Conversely, there was no difference in odds of early HCC detection for Asian (OR, 1.01; 95% CI, 0.97 – 1.05) or Hispanic patients (OR, 0.87; 95% CI, 0.74 – 1.01) compared with White patients. The most common limitation of studies was risk of residual confounding from socioeconomic status and liver dysfunction. Conclusions There are significant racial and ethnic disparities in HCC prognosis in the United States, with Black patients having worse overall survival and Hispanic and Asian patients having better overall survival compared with White patients. Interventions are needed to reduce disparities in early HCC detection to improve HCC prognosis. Hepatocellular carcinoma (HCC) is the fastest rising cause of cancer-related death in the United States; however, HCC incidence and mortality are not equally distributed among racial and ethnic groups. Our aim was to characterize the direction and magnitude of racial and ethnic disparities in overall survival and early tumor detection among patients with HCC. We searched MEDLINE, EMBASE and Cochrane databases from inception through August 2020 for studies reporting HCC outcomes (early stage presentation and overall survival) by race and ethnicity. We calculated pooled hazard ratios (HRs) and odds ratios (ORs) for each racial and ethnic group (White, Black, Hispanic, Asian) using the DerSimonian and Laird method for a random-effects model. We identified 35 articles comprising 563,097 patients (53.0% White, 17.3% Black, 18.4% Hispanic, 5.0% Asian). Compared with White patients, Black patients had worse survival (pooled HR 1.08; 95% CI, 1.05 – 1.12), whereas Hispanic (pooled HR 0.92; 95% CI, 0.87 – 0.97) and Asian (pooled HR 0.81; 95% CI, 0.73 – 0.88) patients had better survival. Among articles reporting tumor stage (n = 20), Black patients had lower odds of early stage HCC compared with White patients (OR, 0.66; 95% CI, 0.54 – 0.78). Conversely, there was no difference in odds of early HCC detection for Asian (OR, 1.01; 95% CI, 0.97 – 1.05) or Hispanic patients (OR, 0.87; 95% CI, 0.74 – 1.01) compared with White patients. The most common limitation of studies was risk of residual confounding from socioeconomic status and liver dysfunction. There are significant racial and ethnic disparities in HCC prognosis in the United States, with Black patients having worse overall survival and Hispanic and Asian patients having better overall survival compared with White patients. Interventions are needed to reduce disparities in early HCC detection to improve HCC prognosis." @default.
- W3117103641 created "2021-01-05" @default.
- W3117103641 creator A5011547093 @default.
- W3117103641 creator A5014214683 @default.
- W3117103641 creator A5063757075 @default.
- W3117103641 creator A5074588012 @default.
- W3117103641 creator A5085283718 @default.
- W3117103641 date "2022-02-01" @default.
- W3117103641 modified "2023-10-17" @default.
- W3117103641 title "Racial and Ethnic Disparities in Survival Among Patients With Hepatocellular Carcinoma in the United States: A Systematic Review and Meta-Analysis" @default.
- W3117103641 cites W1548660409 @default.
- W3117103641 cites W1552401122 @default.
- W3117103641 cites W1874330936 @default.
- W3117103641 cites W1926202003 @default.
- W3117103641 cites W1974651000 @default.
- W3117103641 cites W1974669017 @default.
- W3117103641 cites W1992147763 @default.
- W3117103641 cites W2003296042 @default.
- W3117103641 cites W2007091489 @default.
- W3117103641 cites W2011025405 @default.
- W3117103641 cites W2014733887 @default.
- W3117103641 cites W2028980317 @default.
- W3117103641 cites W2059743400 @default.
- W3117103641 cites W2063997416 @default.
- W3117103641 cites W2065164285 @default.
- W3117103641 cites W2074052050 @default.
- W3117103641 cites W2133423856 @default.
- W3117103641 cites W2134833483 @default.
- W3117103641 cites W2136381548 @default.
- W3117103641 cites W2139479559 @default.
- W3117103641 cites W2147172608 @default.
- W3117103641 cites W2315027248 @default.
- W3117103641 cites W2341369626 @default.
- W3117103641 cites W2509529148 @default.
- W3117103641 cites W2524442417 @default.
- W3117103641 cites W2527809108 @default.
- W3117103641 cites W2531477027 @default.
- W3117103641 cites W2564125657 @default.
- W3117103641 cites W2573493619 @default.
- W3117103641 cites W2576664927 @default.
- W3117103641 cites W2582878252 @default.
- W3117103641 cites W2591717879 @default.
- W3117103641 cites W2593742819 @default.
- W3117103641 cites W2597872842 @default.
- W3117103641 cites W274428048 @default.
- W3117103641 cites W2766421257 @default.
- W3117103641 cites W2780466521 @default.
- W3117103641 cites W2783446006 @default.
- W3117103641 cites W2795440260 @default.
- W3117103641 cites W2796067155 @default.
- W3117103641 cites W2806581056 @default.
- W3117103641 cites W2883834863 @default.
- W3117103641 cites W2892203602 @default.
- W3117103641 cites W2896091580 @default.
- W3117103641 cites W2898043524 @default.
- W3117103641 cites W2902264768 @default.
- W3117103641 cites W2903020030 @default.
- W3117103641 cites W2912190889 @default.
- W3117103641 cites W2913746470 @default.
- W3117103641 cites W2940251541 @default.
- W3117103641 cites W2964932393 @default.
- W3117103641 cites W2968470226 @default.
- W3117103641 cites W2978728794 @default.
- W3117103641 cites W2981955644 @default.
- W3117103641 cites W2984554553 @default.
- W3117103641 cites W3004642728 @default.
- W3117103641 cites W3021721319 @default.
- W3117103641 cites W3024792955 @default.
- W3117103641 cites W3025561831 @default.
- W3117103641 cites W3037572922 @default.
- W3117103641 cites W3045752464 @default.
- W3117103641 cites W3047829723 @default.
- W3117103641 cites W3087673141 @default.
- W3117103641 cites W3128646645 @default.
- W3117103641 cites W3160680832 @default.
- W3117103641 cites W3165773505 @default.
- W3117103641 cites W3214292365 @default.
- W3117103641 doi "https://doi.org/10.1016/j.cgh.2020.12.029" @default.
- W3117103641 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8243558" @default.
- W3117103641 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33387668" @default.
- W3117103641 hasPublicationYear "2022" @default.
- W3117103641 type Work @default.
- W3117103641 sameAs 3117103641 @default.
- W3117103641 citedByCount "24" @default.
- W3117103641 countsByYear W31171036412021 @default.
- W3117103641 countsByYear W31171036412022 @default.
- W3117103641 countsByYear W31171036412023 @default.
- W3117103641 crossrefType "journal-article" @default.
- W3117103641 hasAuthorship W3117103641A5011547093 @default.
- W3117103641 hasAuthorship W3117103641A5014214683 @default.
- W3117103641 hasAuthorship W3117103641A5063757075 @default.
- W3117103641 hasAuthorship W3117103641A5074588012 @default.
- W3117103641 hasAuthorship W3117103641A5085283718 @default.
- W3117103641 hasBestOaLocation W31171036412 @default.
- W3117103641 hasConcept C120665830 @default.
- W3117103641 hasConcept C121332964 @default.
- W3117103641 hasConcept C126322002 @default.
- W3117103641 hasConcept C137403100 @default.